Daniel Dykas, MBA
About Daniel Dykas, MBA
Daniel Dykas, MBA, serves as the Laboratory Supervisor at Yale University, where he ensures compliance with clinical regulations and develops client retention strategies. With expertise in genetic testing operations and data analysis, he has contributed to innovative studies in personalized medicine since 2003.
Work at Yale University
Daniel Dykas has served as Laboratory Supervisor at Yale University since 2003, contributing over 21 years of experience in the field. In this role, he ensures compliance with CLIA, clinical accrediting agencies, and State of Connecticut regulations for clinical laboratories. He plays a vital part in overseeing high-complexity genetic testing operations at the Yale DNA Diagnostics Laboratory. His responsibilities include coordinating and supervising staff in clinical genetic testing, with a focus on cancer genomics, bioinformatics, quality control, assay development, and medical informatics.
Education and Expertise
Daniel Dykas holds a Bachelor of Science degree in Biology from Charter Oak State College, where he studied from 2000 to 2005. He furthered his education by obtaining a Master of Business Administration (MBA) with a concentration in Healthcare from the University of New Haven, completing his studies from 2015 to 2019. His educational background equips him with a strong foundation in both scientific and business principles, enhancing his effectiveness in laboratory management and operations.
Laboratory Management and Compliance
In his role as Laboratory Supervisor, Daniel Dykas develops client retention strategies and services aimed at clinicians and business partners. He enhances the promotion of laboratory services to potential clients, ensuring that the laboratory meets regulatory standards. His expertise in data analysis using Excel and data processing with Linux, along with proficiency in EPIC EMR and Beaker Laboratory Management software, supports his efforts in maintaining high-quality laboratory operations.
Patient Care and Innovative Studies
Daniel Dykas leads the formulation and implementation of patient care processes for innovative studies and personalized medicine. He collaborates with university and hospital administration to enhance patient care initiatives. His role as a key consultant and manager for the Laboratory Director at the Yale DNA Diagnostics Laboratory underscores his commitment to advancing genetic testing and personalized medicine.